SII stopped manufacturing Covishield since December 2021, says 'disclosed side effects details in packaging insert'
SII stopped Covishield extra doses due to lawsuit, disclosed rare Thrombosis. Advocates govt collaboration. AstraZeneca withdraws Vaxzevria marketing authorisations globally. European Medicines Agency confirms Vaxzevria discontinuation in EU.
|
||||
You Might Like💡 newsR Knowledge: Other News MentionsOxford–AstraZeneca COVID-19 vaccine Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca1 in 3 Covaxin recipients hit by adverse events: StudyNearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The..IndiaTimes Lok Sabha Elections 2024: SP Chief Akhilesh Yadav Talks Exclusively with Oneindia in Mainpuri, UP Credit: Oneindia Duration: 02:44Published AstraZeneca British pharmaceutical companyAstraZeneca pulls its COVID-19 vaccine from the European market Credit: FRANCE 24 English Duration: 01:37Published AstraZeneca requests European authorisation of Covid vaccine be pulled Credit: euronews (in English) Duration: 00:35Published AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court Credit: Oneindia Duration: 05:11Published |